BT3 DCF Valuation - Lineage Cell Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

L

Watchlist Manager

Watchlist

Price: 1.144 EUR 2.14% Market Closed

Market Cap: €215.9m

	Lineage Cell Therapeutics Inc F:BT3	US
	Limbach Holdings Inc F:J4B	US
	GomSpace Group AB F:1G2	SE
	Novartis AG F:NOT	CH
	Innovatec SpA MIL:INC	IT
A	Aristocrat Leisure Ltd XMUN:AC8	AU
A	Ascendis Pharma A/S F:A71	DK
O	Olin Corp SWB:OLN	US
	Panthera Resources PLC OTC:PATRF	UK

BT3's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

Continue BT3 Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

XBER • EUR

BT3

TASE • ILS

LCTX

AMEX • USD

LCTX

Join 347,400+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.